BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31422520)

  • 1. Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin.
    Houghton DE; Lekah A; Macedo TA; Hodge D; Saadiq RA; Little Y; Casanegra AI; McBane RD; Wysokinski WE
    J Thromb Thrombolysis; 2020 Feb; 49(2):199-205. PubMed ID: 31422520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rivaroxaban versus warfarin in the prevention of post-thrombotic syndrome.
    Jeraj L; Jezovnik MK; Poredos P
    Thromb Res; 2017 Sep; 157():46-48. PubMed ID: 28692839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.
    Ferreira T; Huber SC; de Moraes Martinelli B; Junior AL; Menezes FH; Orsi FA; Bittar LF; de Oliveira LFG; Sodre LR; Mello TT; Rielli G; Colella MP; de Paula EV; Yamaguti-Hayakawa GG; Montalvão S; Annichino-Bizzacchi JM
    Vascul Pharmacol; 2020 Jan; 124():106608. PubMed ID: 31678199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis.
    Hanafy AS; Abd-Elsalam S; Dawoud MM
    Vascul Pharmacol; 2019 Feb; 113():86-91. PubMed ID: 29886103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome.
    Utne KK; Dahm A; Wik HS; Jelsness-Jørgensen LP; Sandset PM; Ghanima W
    Thromb Res; 2018 Mar; 163():6-11. PubMed ID: 29324334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of deep vein thrombosis with rivaroxaban and its potential to prevent the post-thrombotic syndrome.
    Antignani PL; Allegra C; Fareed J
    Int Angiol; 2019 Feb; 38(1):17-21. PubMed ID: 30465419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
    Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
    Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
    Piazza G; Mani V; Goldhaber SZ; Grosso MA; Mercuri M; Lanz HJ; Schussler S; Hsu C; Chinigo A; Ritchie B; Nadar V; Cannon K; Pullman J; Concha M; Schul M; Fayad ZA;
    Vasc Med; 2016 Aug; 21(4):361-8. PubMed ID: 27165711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of hospital visits among patients with deep vein thrombosis treated with rivaroxaban and LMWH/warfarin.
    Merli GJ; Hollander JE; Lefebvre P; Laliberté F; Raut MK; Germain G; Bookhart B; Pollack CV
    J Med Econ; 2016; 19(1):84-90. PubMed ID: 26390315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB; Skjøth F; Kjældgaard JN; Lip GYH; Nielsen PB; Søgaard M
    Lancet Haematol; 2017 May; 4(5):e237-e244. PubMed ID: 28411120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis.
    Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö
    Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of upper extremity deep vein thrombosis with apixaban and rivaroxaban.
    Houghton DE; Casanegra AI; Peterson LG; Cochuyt J; Hodge DO; Vlazny D; McBane RD; Froehling D; Wysokinski WE
    Am J Hematol; 2020 Jul; 95(7):817-823. PubMed ID: 32267011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of rivaroxaban in postoperative deep vein thrombosis of the lower limb following instability with warfarin: a case report.
    Schiavoni M; Coluccia A
    J Med Case Rep; 2016 Oct; 10(1):276. PubMed ID: 27716428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions.
    Margolis JM; Deitelzweig S; Kline J; Tran O; Smith DM; Bookhart B; Crivera C; Schein J
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.
    Sebastian T; Hakki LO; Spirk D; Baumann FA; Périard D; Banyai M; Spescha RS; Kucher N; Engelberger RP
    Thromb Res; 2018 Dec; 172():86-93. PubMed ID: 30391776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program.
    Matsuo H; Prins M; Lensing AW; Fujinuma EW; Miyamoto Y; Kajikawa M
    Curr Med Res Opin; 2015 Jun; 31(6):1057-61. PubMed ID: 25851062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin.
    de Athayde Soares R; Matielo MF; Brochado Neto FC; Nogueira MP; Almeida RD; Sacilotto R
    Surgery; 2019 Dec; 166(6):1076-1083. PubMed ID: 31277885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis.
    Hsu C; Brahmandam A; Brownson KE; Huynh N; Reynolds J; Lee AI; Fares WH; Ochoa Chaar CI
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):169-175.e4. PubMed ID: 30660579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of Treating Venous Thromboembolism With Heparin and Warfarin Versus Home Treatment With Rivaroxaban.
    Kahler ZP; Beam DM; Kline JA
    Acad Emerg Med; 2015 Jul; 22(7):796-802. PubMed ID: 26111453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.